A partnership of scientists and officials from Wales and Germany has been able to identify candidate biomarkers present in the breath of someone affected by Covid-19.
The technology allowing for detection of the virus in a patient’s breath was developed as part of the TOXI-Triage project at Loughborough University in Leicestershire. Partners from IMSPEX Group – Ion Mobility Spectrometry (IMS) specialists – as well as the Royal Infirmary of Edinburgh and Germany’s Klinikum Dortmund Hospital, have utilized the technology to achieve certain results. The aim is to detect “breath signatures” that can be used to rapidly distinguish Covid-19 from other respiratory conditions at point of need.
